Nov 19, 2018 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.
Nov 21, 2018 - A collection of hedge funds' favorite stock picks — including Facebook, Alibaba and Amazon — is underperforming the broader equity market in the second half of 2018.
Nov 26, 2018 - VK-2809 has neither clinical data nor an IND in NASH and its development lags 2.5 - 3 years behind MGL-3196.Even if successful in a NASH trial, VK-2809 will be competing in a crowded space with variou
Dec 03, 2018 - UBS Global Wealth Management says the new assessments of equity and bond funds will include pollution, ethics and climate change.
Dec 06, 2018 - THW is a Tekla healthcare fund much like THQ, but with an emphasis on holding global securities.THW currently has a quite attractive 10.55% yield.This fund is also showing a discount of 8.29%, but tha
Dec 13, 2018 - Bausch (BHC) bids to acquire certain assets of Synergy Pharma for $200 million.
Dec 19, 2018 - Synergy filed for bankruptcy after failing to amend the liquidity and revenue covenants of its loan facility with private lender CRG.Bausch Health has offered $200 million for its assets; other bids m
Jan 04, 2019 - Allergan (AGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Jan 04, 2019 - Merck takes option to license NGM313 drug for NASH, which will be used in a phase 2 study known under a different name as MRK-3655.The main deal between Merck & NGM Bio was $450 million to develop bio
Jan 11, 2019 - Lilly (LLY) is spending $8 billion to buy small cancer biotech Loxo Oncology. Big Pharma CEOs hint at spur in M&A activity in 2019.